Seminar

Seminar

Date:
13 January 2012 00:00 hrs.
Location:
Title:
HMGB1: a potent activator of dendritic cells in SLE
Speaker(s):

Prof. Reinhard Voll, Head of the Dept. of Rheumatology, University Hospital Freiburg, Germany

Host(s):

Prof. Jo Berden, Dept. of Nephrology

13-01-2012 00:00:00Europe/AmsterdamHMGB1: a potent activator of dendritic cells in SLE Rimlsrimls@radboudumc.nl

Remarks / more information:

Voll , ReinhardBecause of the PhD ceremony of Justin Fransen prof. Reinhard Voll will visit us. Prof. Voll is head of the Dept. of Rheumatology at the University Hospital in Freiburg. He was the first who reported on the use of bortezomib in SLE (Nature Med 2008;14:748-55). During his research he focused on the role of apoptosis in SLE and has published several high impact papers on this subject. This includes a number of studies on dendritic cell activation by HMGB1 (J Exp Med 2008;22:3007-18).



<< back to all events